Age-adjusted antitumoral therapy based on the demonstration of increased apoptosis as a mechanism underlying the reduced malignancy of tumors in the aged

Orit Itzhaki, Tatiana Kaptzan, Ehud Skutelsky, Judith Sinai, Moshe Michowitz, Annette Siegal, Ginnette Schibi, Monica Huszar, Lya Ben-Dor, Judith Leibovici*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

In view of the constant increase in the aged population, age-adjusted cancer therapy becomes an urgent target. Although cancer incidence rises with age, paradoxically, growth rate and metastasis often proceed at a slower rate in the aged. Determining the mechanism(s) underlying this reduced tumor progression in the old might have implications for a rational design of age-adjusted therapy. Thus far, decreased cell proliferation or immune response modifications were suggested as possible mechanisms. We show here that an increased tendency to apoptotic tumor cell death in the aged could constitute an additional mechanism. Based on this mechanism, we compared the therapeutic efficacy of two apoptosis inducers, hydrocortisone and adriamycin, on AKR lymphoma and B16 melanoma growth in young and old mice. Treatment with hydrocortisone acetate inhibited tumor growth practically only in old mice in the two tumor systems. Similar effects were obtained with adriamycin treatment of AKR lymphoma but opposite results were seen with B16 melanoma. We thus demonstrated, in three of the four tumor-therapeutic modality systems examined, an age-related antitumoral efficacy of two apoptosis-inducing agents, with tendency for a remarkably more pronounced effect in aged mice.

Original languageEnglish
Pages (from-to)145-159
Number of pages15
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1688
Issue number2
DOIs
StatePublished - 2 Mar 2004

Funding

FundersFunder number
Katznelbogen Grant for Melanoma Research

    Keywords

    • Age-dependent therapy design
    • Aging
    • Apoptosis induction
    • Cancer treatment
    • Tumor progression

    Fingerprint

    Dive into the research topics of 'Age-adjusted antitumoral therapy based on the demonstration of increased apoptosis as a mechanism underlying the reduced malignancy of tumors in the aged'. Together they form a unique fingerprint.

    Cite this